Underrepresentation of the elderly in clinical trials, time for action.
作者信息
van Marum Rob J
机构信息
Department of General Practice and Elderly Care Medicine, Amsterdam Public Health Research Institute, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands.
Departments of Clinical Pharmacology and Geriatrics, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands.
出版信息
Br J Clin Pharmacol. 2020 Oct;86(10):2014-2016. doi: 10.1111/bcp.14539. Epub 2020 Sep 9.
Abstract
摘要
相似文献
1
Underrepresentation of the elderly in clinical trials, time for action.老年人在临床试验中的代表性不足，是采取行动的时候了。
Br J Clin Pharmacol. 2020 Oct;86(10):2014-2016. doi: 10.1111/bcp.14539. Epub 2020 Sep 9.
2
Increasing underrepresentation of elderly patients with advanced colorectal or non-small-cell lung cancer in chemotherapy trials.晚期结直肠癌或非小细胞肺癌老年患者在化疗试验中的代表性越来越低。
Intern Med J. 2006 Apr;36(4):216-20. doi: 10.1111/j.1445-5994.2006.01033.x.
3
Applicability of trials in rheumatoid arthritis and osteoarthritis: A systematic review and meta-analysis of trial populations showing adequate proportion of women, but underrepresentation of elderly people.类风湿关节炎和骨关节炎临床试验的适用性：一项系统评价和荟萃分析显示，试验人群中女性比例充足，但老年人代表性不足。
Semin Arthritis Rheum. 2019 Jun;48(6):983-989. doi: 10.1016/j.semarthrit.2018.10.017. Epub 2018 Nov 2.
4
Advancing Treatment Approach to the Older Patient with Cancer Through Clinical Trials Participation.通过参与临床试验推进老年癌症患者的治疗方法
Surg Oncol Clin N Am. 2017 Oct;26(4):719-728. doi: 10.1016/j.soc.2017.05.010. Epub 2017 Aug 4.
5
Older adults in hematologic malignancy trials: Representation, barriers to participation and strategies for addressing underrepresentation.血液恶性肿瘤试验中的老年人：代表性、参与障碍及解决代表性不足的策略。
Blood Rev. 2020 Sep;43:100670. doi: 10.1016/j.blre.2020.100670. Epub 2020 Feb 7.
6
Impact of age and comorbidity on treatment and outcomes in elderly cancer patients.老年癌症患者的年龄和合并症对治疗和结局的影响。
Semin Radiat Oncol. 2012 Oct;22(4):265-71. doi: 10.1016/j.semradonc.2012.05.002.
7
Cancer treatment protocols. Who gets chosen?癌症治疗方案。哪些人会被选中？
Arch Intern Med. 1988 Oct;148(10):2258-60.
8
[Development of a charter for older people in clinical trials: PREDICT].[制定临床试验中老年人宪章：PREDICT]
Tijdschr Gerontol Geriatr. 2009 Oct;40(5):180-3. doi: 10.1007/BF03079586.
9
Under-representation of the elderly in cancer clinical trials.老年人在癌症临床试验中的代表性不足。
Br J Hosp Med (Lond). 2010 Dec;71(12):678-81. doi: 10.12968/hmed.2010.71.12.678.
10
Inclusion of Older People Reflective of Real-World Clinical Practice in Cardiovascular Drug Trials.心血管药物试验纳入老年人反映了真实世界的临床实践。
J Am Heart Assoc. 2020 Nov 3;9(21):e016936. doi: 10.1161/JAHA.120.016936. Epub 2020 Oct 26.
引用本文的文献
1
Safety of fruquintinib in Chinese patients with colorectal cancer: an age subgroup analysis from a phase IV real-world clinical practice study.呋喹替尼在中国结直肠癌患者中的安全性：一项IV期真实世界临床实践研究的年龄亚组分析
Ther Adv Med Oncol. 2025 Sep 1;17:17588359251363537. doi: 10.1177/17588359251363537. eCollection 2025.
2
Potential Drug Dose-Specific Adverse Three-Drug Combinations: A US Insurance Claims Data-Based Study.潜在的特定药物剂量的三联药物组合不良事件：一项基于美国保险理赔数据的研究。
Pharmacoepidemiol Drug Saf. 2025 Sep;34(9):e70199. doi: 10.1002/pds.70199.
3
Age and Sex Differences in Adverse Events Associated With Antipsychotics: An Analysis of the FDA Adverse Events Database.抗精神病药物相关不良事件的年龄和性别差异：对美国食品药品监督管理局不良事件数据库的分析
Int J Geriatr Psychiatry. 2025 Aug;40(8):e70142. doi: 10.1002/gps.70142.
4
Precision Medicine: Personalizing Healthcare by Bridging Aging, Genetics, and Global Diversity.精准医学：通过弥合衰老、遗传学和全球多样性实现医疗保健个性化。
Healthcare (Basel). 2025 Jun 26;13(13):1529. doi: 10.3390/healthcare13131529.
5
Clinical and economic burden among older adults with acromegaly in the United States.美国肢端肥大症老年患者的临床和经济负担
J Comp Eff Res. 2025 Sep;14(9):e250076. doi: 10.57264/cer-2025-0076. Epub 2025 Jul 8.
6
Equity in neuromuscular research: a 20-year analysis of race, ethnicity, sex, and age representation.神经肌肉研究中的公平性：对种族、民族、性别和年龄代表性的20年分析
J Neurol. 2025 Jun 30;272(7):483. doi: 10.1007/s00415-025-13208-8.
7
An examination of factors associated with disparities in clinical trial eligibility guided by the Socioecological Model.一项以社会生态模型为指导，对与临床试验资格差异相关因素的考察。
Cancer. 2025 Jul 1;131(13):e35944. doi: 10.1002/cncr.35944.
8
Estimation of the biological variation of IGF-I in multimorbid geriatric patients and its clinical implications.多病症老年患者中胰岛素样生长因子-I（IGF-I）生物学变异的评估及其临床意义。
Pituitary. 2025 May 10;28(3):59. doi: 10.1007/s11102-025-01530-3.
9
A theoretical model for detecting drug interaction with awareness of timing of exposure.一种用于检测药物相互作用并知晓暴露时间的理论模型。
Sci Rep. 2025 Apr 21;15(1):13693. doi: 10.1038/s41598-025-98528-5.
10
Drug safety in healthy aging.健康老龄化中的药物安全性。
NPJ Aging. 2025 Apr 12;11(1):28. doi: 10.1038/s41514-025-00220-5.
本文引用的文献
1
Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis.多种药物联合使用及超量多种药物联合使用与衰弱状态的关联：一项系统评价和荟萃分析
Eur Geriatr Med. 2019 Feb;10(1):9-36. doi: 10.1007/s41999-018-0124-5. Epub 2018 Nov 7.
2
Treatment of hypercholesterolaemia in older adults calls for a patient-centred approach.老年高胆固醇血症的治疗需要采取以患者为中心的方法。
Heart. 2020 Feb;106(4):261-266. doi: 10.1136/heartjnl-2019-315600. Epub 2019 Nov 28.
3
Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials.癌症临床试验中年龄上限标准的纳入标准降低。
J Geriatr Oncol. 2020 Apr;11(3):451-454. doi: 10.1016/j.jgo.2019.11.001. Epub 2019 Nov 8.
4
Prescribing medicines to older people-How to consider the impact of ageing on human organ and body functions.给老年人开药——如何考虑衰老对人体器官和身体功能的影响。
Br J Clin Pharmacol. 2020 Oct;86(10):1921-1930. doi: 10.1111/bcp.14094. Epub 2019 Dec 16.
5
Adequacy of Inclusion of Older Adults in NIH-Funded Phase III Clinical Trials.纳入老年人参与 NIH 资助的 III 期临床试验的充分性。
J Am Geriatr Soc. 2019 Feb;67(2):218-222. doi: 10.1111/jgs.15786. Epub 2019 Jan 29.
6
Under-representation of elderly in clinical trials: An analysis of the initial approval documents in the Food and Drug Administration database.临床试验中老年人代表性不足：对食品和药物管理局数据库中初始批准文件的分析。
Br J Clin Pharmacol. 2019 Apr;85(4):838-844. doi: 10.1111/bcp.13876. Epub 2019 Feb 23.
7
Exclusion of Elderly People from Randomized Clinical Trials of Drugs for Ischemic Heart Disease.老年人群被排除在缺血性心脏病药物随机临床试验之外。
J Am Geriatr Soc. 2017 Nov;65(11):2354-2361. doi: 10.1111/jgs.14833. Epub 2017 Mar 17.
8
Adverse drug reactions in special populations - the elderly.特殊人群中的药物不良反应——老年人
Br J Clin Pharmacol. 2015 Oct;80(4):796-807. doi: 10.1111/bcp.12596. Epub 2015 May 22.
9
Participation of older people in preauthorization trials of recently approved medicines.老年人参与近期获批药物的预授权试验。
J Am Geriatr Soc. 2014 Oct;62(10):1883-90. doi: 10.1111/jgs.13067. Epub 2014 Oct 3.
10
Exclusion of older adults from ongoing clinical trials about type 2 diabetes mellitus.将老年人排除在正在进行的 2 型糖尿病临床试验之外。
J Am Geriatr Soc. 2013 May;61(5):734-8. doi: 10.1111/jgs.12215. Epub 2013 Apr 16.
Zotero 插件